Recursion Pharmaceuticals, Inc. (RXRX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Recursion Pharmaceuticals, Inc. (RXRX)
Go deeper and ask any question about RXRX
Company Performance
Current Price
as of Sep 13, 2024$6.57
P/E Ratio
N/A
Market Cap
$1.81B
Description
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Metrics
Overview
- HQSalt Lake City, UT
- SectorHealth Technology
- IndustryBiotechnology
- TickerRXRX
- Price$6.57+1.08%
Trading Information
- Market Cap$1.81B
- Float77.41%
- Average Daily Volume (1m)4,625,920
- Average Daily Volume (3m)5,730,574
- EPS-$1.62
Company
- Revenue$49.64M
- Rev Growth (1yr)30.86%
- Net Income-$97.54M
- Gross Margin9.14%
- EBITDA Margin-641.90%
- EBITDA-$92.54M
- EV$1.43B
- EV/Revenue28.81
- P/EN/A
- P/S32.06